Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2021 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
AURA on Nasdaq
Shares outstanding
62,124,648
Price per share
$5.68
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
50,234,935
Total reported value
$273,791,080
% of total 13F portfolios
0%
Share change
-1,519,014
Value change
-$8,935,762
Number of holders
116
Price from insider filings
$5.68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Matrix Capital Management Company, LP 11% $38,214,242 6,922,870 Matrix Capital Management Company LP 16 May 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.6% +25% $30,091,360 +$10,524,518 4,701,775 +54% Suvretta Capital Management, LLC 30 Jun 2025
Frazier Life Sciences Public Fund, L.P. 6.3% +26% $20,523,185 +$4,675,216 4,032,060 +30% Frazier Life Sciences Public Fund, L.P. 31 Dec 2025
BlackRock, Inc. 5.4% +10% $20,617,314 +$1,842,342 3,336,027 +9.8% BlackRock, Inc. 30 Sep 2025
Long Focus Capital Management, LLC 6.6% +75% $18,324,093 +$4,481,180 3,319,582 +32% LONG FOCUS CAPITAL MANAGEMENT, LLC 31 Mar 2025
Advent Life Sciences LLP 3.3% $11,768,148 2,071,857 Rajesh Parekh, Ph.D. 13 Feb 2026

As of 31 Dec 2025, 116 institutional investors reported holding 50,234,935 shares of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA). This represents 81% of the company’s total 62,124,648 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) together control 77% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Matrix Capital Management Company, LP 11% 6,922,870 0% 65% $37,729,642
Frazier Life Sciences Management, L.P. 8.2% 5,100,000 0% 0.75% $27,795,000
ADAGE CAPITAL PARTNERS GP, L.L.C. 7.9% 4,881,125 0% 0.04% $26,602,131
Long Focus Capital Management, LLC 7.4% 4,619,582 0% 1.3% $25,176,722
SUVRETTA CAPITAL MANAGEMENT, LLC 7% 4,372,884 0% 0.59% $23,832,218
BlackRock, Inc. 5.7% 3,560,424 +4.5% 0% $19,404,310
Medicxi Ventures Management (Jersey) Ltd 4.9% 3,039,892 0% 2% $16,567,411
VANGUARD GROUP INC 4.7% 2,936,538 +1.6% 0% $16,004,132
FRANKLIN RESOURCES INC 3.5% 2,198,423 -0.02% 0% $11,981,405
Nantahala Capital Management, LLC 3.4% 2,117,697 0% 0.69% $11,541,449
GEODE CAPITAL MANAGEMENT, LLC 2% 1,255,450 -0.2% 0% $6,845,107
LEVIN CAPITAL STRATEGIES, L.P. 1.7% 1,035,586 -36% 0.49% $5,643,944
STATE STREET CORP 1.5% 926,534 +5.4% 0% $5,049,610
MILLENNIUM MANAGEMENT LLC 0.99% 617,338 +233% 0% $3,364,492
ACORN CAPITAL ADVISORS, LLC 0.96% 595,744 0% 1.1% $3,246,805
B Group, Inc. 0.92% 572,576 0% 2.3% $3,120,539
Regency Capital Management Inc.\DE 0.87% 538,584 -12% 1.2% $2,935,283
DIMENSIONAL FUND ADVISORS LP 0.83% 517,916 +4.2% 0% $2,822,824
PRICE T ROWE ASSOCIATES INC /MD/ 0.71% 442,789 -8% 0% $2,415,000
NORTHERN TRUST CORP 0.66% 412,809 -4.8% 0% $2,249,809
Decheng Capital LLC 0.58% 360,483 -30% 0.26% $1,964,632
MORGAN STANLEY 0.35% 218,407 +22% 0% $1,190,319
UBS Group AG 0.28% 171,639 -81% 0% $935,433
BANK OF AMERICA CORP /DE/ 0.27% 165,185 +357% 0% $900,259
RENAISSANCE TECHNOLOGIES LLC 0.23% 145,200 +49% 0% $791,340

Institutional Holders of Aura Biosciences, Inc. - Common Stock, par value $0.00001 per share (AURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 50,234,935 $273,791,080 -$8,935,762 $5.45 116
2025 Q3 51,649,516 $319,192,259 +$6,254,107 $6.18 106
2025 Q2 50,616,053 $316,863,119 +$67,408,487 $6.26 102
2025 Q1 39,264,901 $230,096,030 -$11,860,142 $5.86 91
2024 Q4 39,449,434 $324,276,778 +$16,157,250 $8.22 93
2024 Q3 36,866,668 $329,191,609 -$25,783,402 $8.91 81
2024 Q2 39,765,227 $300,437,451 +$3,314,060 $7.56 75
2024 Q1 39,115,323 $307,072,789 +$16,222,241 $7.85 77
2023 Q4 36,998,812 $327,811,496 +$89,731,106 $8.86 71
2023 Q3 26,323,010 $236,119,190 -$5,574,466 $8.97 62
2023 Q2 27,066,492 $334,426,517 +$24,980,886 $12.35 59
2023 Q1 25,069,599 $232,645,346 +$10,922,124 $9.28 57
2022 Q4 23,806,818 $250,037,016 +$78,469,205 $10.50 49
2022 Q3 16,317,002 $295,663,462 +$9,714,465 $18.12 43
2022 Q2 15,793,428 $223,796,376 +$29,644,466 $14.17 42
2022 Q1 13,702,730 $298,756,000 +$9,092,301 $22.00 34
2021 Q4 13,081,587 $220,131,000 +$220,131,000 $16.98 32